| View |
LRV2024-02-28-0072
|
TETANUS TOXOID (ADSORBED)
|
ABHAY-TOX
|
BR-1370
|
22GTOX016B
|
Packaging Lot (Box and Vial): 22GTOX016B
|
31-May-25
|
05 March 2024
|
| View |
2023-01-04-0004
|
MENINGOCOCCAL GROUP A, C, W-135 AND Y CONJUGATE VACCINE
|
MENQUADFI
|
BR-1388
|
U7672A
|
Packaging Lot (Box and Vial): U7672AD
|
31-May-26
|
10 January 2023
|
| View |
LRV2023-09-28-0314
|
HEPATITIS B VACCINE (rDNA)
|
GENVAC-B
|
BR-574
|
0343Q008A
|
Packaging Lot (Box and Vial): 0343Q008A
|
31-May-26
|
03 October 2023
|
| View |
LRV2023-11-09-0368
|
PURIFIED CHICK EMBRYO CELL CULTURE RABIES VACCINE
|
VAXIRAB N
|
BRP-071
|
RV30044
|
Packaging Lot (Box and Tube): RV30044
|
31-May-26
|
15 November 2023
|
| View |
LRV2023-11-23-0379
|
HUMAN PAPILLOMAVIRUS 9-VALENT VACCINE (RECOMBINANT, ADSORBED)
|
GARDASIL 9
|
BR-1168
|
1664333
|
Packaging Lot (Box and PFS): X024229; (Needle 23G x 1"): 2304007/ 2304006; (Needle 25G x 1"): 2303043
|
31-May-26
|
30 November 2023
|
| View |
LRV2023-12-22-0395
|
HERPES ZOSTER VACCINE (RECOMBINANT, ADJUVANTED)
|
SHINGRIX
|
BR-1441
|
A295Z
|
Packaging Lot (Box [vaccine] and Vial [adjuvant]): A295Z
|
31-May-26
|
28 December 2023
|
| View |
LRV2024-01-04-0007
|
HEPATITIS B VACCINE (rDNA)
|
GENVAC-B
|
BR-574
|
0343Q008C
|
Packaging Lot (Box and Vial): 0343Q008C
|
31-May-26
|
09 January 2024
|
| View |
LRV2024-02-15-0055
|
HERPES ZOSTER VACCINE (RECOMBINANT, ADJUVANTED)
|
SHINGRIX
|
BR-1441
|
44BB2
|
Packaging Lot (Box, Vial [vaccine]) and (Vial [adjuvant]): 44BB2
|
31-May-26
|
20 February 2024
|
| View |
LRV2024-02-26-0068
|
LIVE ATTENUATED MEASLES, MUMPS AND RUBELLA VACCINE
|
-
|
BR-911
|
0163W031
|
Packaging Lot (Box and Vial): 0163W031; (Diluent): 0683S1018; 0683S1019
|
31-May-26
|
04 March 2024
|
| View |
LRV2024-02-26-0069
|
LIVE ATTENUATED MEASLES, MUMPS AND RUBELLA VACCINE
|
-
|
BR-911
|
0163W032
|
Packaging Lot (Box and Vial): 0163W032; (Diluent): 0683S1018; 0683S1019
|
31-May-26
|
04 March 2024
|
| View |
LRV2024-05-10-0191
|
HERPES ZOSTER VACCINE (RECOMBINANT, ADJUVANTED)
|
SHINGRIX
|
BR-1441
|
AR4C2
|
Packaging Lot (Box, Vial) Vaccine; and (Vial) Adjuvant: AR4C2
|
31-May-26
|
16 May 2024
|
| View |
LRV2024-06-10-0238
|
HEPATITIS B VACCINE (rDNA)
|
GENVAC-B
|
BR-567
|
0323X018F
|
Packaging Lot (Box and Vial): 0323X018F
|
31-May-26
|
19 June 2024
|
| View |
LRV2024-06-10-0239
|
HEPATITIS B VACCINE (rDNA)
|
GENVAC-B
|
BR-567
|
0323X019B
|
Packaging Lot (Box and Vial): 0323X019B
|
31-May-26
|
19 June 2024
|
| View |
LRV2024-07-02-0279
|
INACTIVATED POLIOMYELITIS VACCINE (TYPES 1, 2 AND 3)
|
IMOVAX POLIO
|
BR-498
|
X2A33
|
Packaging Lot (Box): X2A334V; (PFS): X2A33
|
31-May-26
|
05 July 2024
|
| View |
LRV2024-07-05-0285
|
TYPHOID POLYSACCHARIDE VACCINE
|
TYPHIM VI
|
BR-280
|
X2A46
|
Packaging Lot (Box and PFS): X2A463V
|
31-May-26
|
11 July 2024
|
| View |
LRV2024-08-15-0381
|
HUMAN NORMAL IMMUNOGLOBULIN (IGIV)
|
GAMMA I.V.
|
BR-636
|
A03324014
|
Packaging Lot (Box and Vial): A03324014
|
31-May-26
|
21 August 2024
|
| View |
LRV2024-08-15-0382
|
HUMAN NORMAL IMMUNOGLOBULIN (IGIV)
|
GAMMA I.V.
|
BR-636
|
A03324013
|
Packaging Lot (Box and Vial): A03324013
|
31-May-26
|
21 August 2024
|
| View |
LRV2024-09-05-0402
|
TYPHOID POLYSACCHARIDE VACCINE
|
TYPHIM VI
|
BR-280
|
X2A47
|
Packaging Lot (Box): X2A475V; (Pre-filled Syringe): X2A47
|
31-May-26
|
10-Sep-24
|
| View |
LRV2024-09-06-0405
|
PNEUMOCOCCAL POLYSACCHARIDE CONJUGATE VACCINE (ADSORBED)
|
SYNFLORIX
|
BR-1310
|
ASP4A437A
|
Packaging Lot (Box and Vial): ASP4A437A
|
31-May-26
|
12-Sep-24
|
| View |
LRV2024-09-06-0408
|
PNEUMOCOCCAL POLYSACCHARIDE CONJUGATE VACCINE (ADSORBED)
|
SYNFLORIX
|
BR-1310
|
ASP4A434A
|
Packing Lot (Box and Vial): ASP4A434A
|
31-May-26
|
12-Sep-24
|